CASI Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.51M $5.92M $6.89M $7.40M $7.48M $5.28M $3.69M $1.94M $0.67M $0.00M $0.02M $0.05M $0.00M $0.00M $0.00M $4.13M $15.14M $30.17M $43.11M $33.88M $0.00M
GM % Gross Margin %
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 68.53% 86.85% 0.00% 0.00% 0.00% 4.74% 37.20% 58.38% 63.28% 59.19% 0.00%
OM Operating Margin
0.00% -292.79% 0.00% 0.00% -272.25% -127.21% -122.78% -235.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -220.02% -116.95% -61.45% -74.62% 0.00%
EPS Earnings Per Share
$-39.60 $-78.11 $-30.80 $-9.40 $-9.20 $-2.20 $-1.70 $-1.80 $-3.16 $-4.07 $-2.76 $-1.82 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0.34m 0.46m 0.67m 0.77m 0.81m 0.8m 1.15m 1.22m 2.25m 2.7m 3.24m 3.24m 6.02m 6.51m 9.53m 9.63m 12.39m 13.98m 13.61m 13.32m 12.99m
OCF Operating Cash Flow
$-16.42M $-14.52M $-20.77M $-23.52M $-20.71M $-10.21M $-4.96M $-4.27M $-2.21M $-3.28M $-4.00M $-5.51M $-6.02M $-6.40M $-28.58M $-23.24M $-25.89M $-26.84M $-21.09M $-19.97M $0.00M
FCF Free Cash Flow
$-16.58M $-14.77M $-21.00M $-23.63M $-20.84M $0.00M $0.00M $-4.28M $-2.26M $-3.32M $-4.23M $-5.54M $-6.24M $-7.33M $-29.71M $-23.67M $-27.39M $-35.79M $-26.70M $-41.74M $0.00M
FCFS Free Cash Flow Per Share
$-49.08 $-33.72 $-32.14 $-30.88 $-26.52 $-12.80 $-5.13 $-3.63 $-1.19 $-1.27 $-1.56 $-1.71 $-1.12 $-1.19 $-5.94 $-3.88 $-3.85 $-3.11 $-1.96 $-1.66 $0.00